1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INSMED INC
Insmed Inc XNAS: INSM

Insmed Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment...

Read More
167.72 -8.25 (-4.69%)
177.68% Gain from 52W Low
4.1M
XNAS Volume

XNAS 12 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The latest board meeting for Insmed Inc took place on 12 Jan 2026, for the purpose of 44th Annual J.P. Morgan Healthcare Conference See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
3.7 / 100
Momentum Score
Technically Neutral
53.3 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
216
1Yr Price target upside is 29%
18 analysts

8

S

18

W

7

O

0

T

SWOT Analysis

Insmed Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..